EQUITY RESEARCH MEMO

Pullan Consulting

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)65/100

Pullan Consulting is a boutique biotech and pharma services firm headquartered in San Diego, founded in 2005. The company specializes in providing expert guidance on strategic partnerships and deal-making, including deal evaluation, negotiation, and execution across research collaborations, licenses, co-development, and acquisitions. Leveraging deep industry experience, Pullan helps clients unlock value and drive growth through strategic alliances. As a trusted advisor, the firm focuses on the critical niche of deal-making support, which remains essential as biotech and pharma companies increasingly rely on partnerships to advance their pipelines. Over its two decades of operation, Pullan has built a strong reputation for delivering actionable insights and facilitating complex transactions. Its boutique nature allows for personalized service and deep engagement with each client. However, as a private consultancy, Pullan's growth is closely tied to client demand and broader market cycles. The firm's ability to maintain long-standing relationships and adapt to evolving industry needs positions it for steady, though not explosive, expansion. With no disclosed financials or major public catalysts, the company represents a stable but modest opportunity in the consulting space.

Upcoming Catalysts (preview)

  • Q2 2027Expansion into New Therapeutic Areas60% success
  • Q4 2026Launch of Digital Deal Analytics Platform50% success
  • Q3 2026Preferred Partnership with a Top 20 Pharma70% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)